NOVEL ANTIVIRAL CANDIDATES TARGETING THE RIBONUCLEASE H FOLD IN HIV AND OTHER VIRUSES AND REVERSE TRANSCRIPTASE ENGINEERING FOR BIOTECHNOLOGY